Bright Green Corp BGXX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
-
BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
-
BRIGHT GREEN ANNOUNCES IT HAS OBTAINED A $3.5 MILLION FUNDING COMMITMENT UNDER AN EXISTING LINE OF CREDIT AND HAS ENGAGED AN INVESTMENT BANK TO SEEK A $15.0 MILLION DEBT FINANCING TO MOVE FORWARD WITH COMMERCIALIZATION.
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.04–0.04
- 52-Week Range
- $0.03–0.54
- Bid/Ask
- $0.04 / $0.04
- Market Cap
- $7.09 Mil
- Volume/Avg
- 121,184 / 771,399
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5
- Website
- https://www.brightgreen.us
Comparables
Valuation
|
Metric
|
BGXX
|
SCLX
|
BKUH
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 251.64 |
Price/Book Value | 0.72 | — | — |
Price/Sales | — | 1.93 | — |
Price/Cash Flow | — | — | — |
Price/Earnings
BGXX
SCLX
BKUH
Financial Strength
|
Metric
|
BGXX
|
SCLX
|
BKUH
|
|---|---|---|---|
Quick Ratio | 0.02 | 0.18 | 0.03 |
Current Ratio | 0.02 | 0.20 | 0.05 |
Interest Coverage | — | −53.88 | −11.18 |
Quick Ratio
BGXX
SCLX
BKUH
Profitability
|
Metric
|
BGXX
|
SCLX
|
BKUH
|
|---|---|---|---|
Return on Assets (Normalized) | −43.13% | −101.46% | −296.30% |
Return on Equity (Normalized) | −69.84% | — | — |
Return on Invested Capital (Normalized) | −60.36% | — | — |
Return on Assets
BGXX
SCLX
BKUH
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Rqrlvtfgy | Mrdj | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Kfbrdlznn | Vktjk | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Gvqrwbmk | Gtxk | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Jhfdxpnn | Thtm | $19.9 Bil | |||
| Viatris Inc
VTRS
| Jdhpqfppq | Xjdd | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bgcfnxk | Ckdd | $13.4 Bil | |||
| Catalent Inc
CTLT
| Smjfhgbdl | Hfnjqs | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Krhqwhtz | Nrgmlx | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Xxkzbbq | Gyp | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dtkkrbkthc | Hzqv | $2.5 Bil |
United States